ELV Q2 2020 Earnings — Elevance Health Inc. Revenue & Financial Results | Market Cap Arena

ELVElevance Health Inc.

$64B

Q2 2020 Earnings

Healthcare Medical - Healthcare Plans

Income Statement

Revenue

$29.3B+14.9% YoY

Gross Profit

$9.7B33.2% margin

Operating Income

$3.4B11.5% margin

Net Income

$2.3B7.8% margin

EPS (Diluted)

$8.91

QoQ Revenue Growth

-1.2%

Cash Flow

Operating Cash Flow

$5.5B

Free Cash Flow

$5.3B

Stock-Based Comp.

$67M

Balance Sheet

Total Assets

$88.0B

Total Liabilities

$53.5B

Stockholders' Equity

$34.5B

Cash & Equivalents

$6.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29.3B	$25.5B	+14.9%
Gross Profit	$9.7B	$5.1B	+90.6%
Operating Income	$3.4B	$1.6B	+104.8%
Net Income	$2.3B	$1.1B	+99.8%

Revenue Segments

Government Business Segment

$17.2B53%

Commercial Specialty Business Segment

$8.8B27%

IngenioRx Segment

$5.3B16%

Other Segment

$1.5B4%